Similar articles

• [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].

  Nitschmann S. Nitschmann S. Internist (Berl). 2006 Feb;47(2):199-200; discussion 200. doi: 10.1007/s00108-005-1560-0. Internist (Berl). 2006. PMID: 16416298 German. No abstract available.
• Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.

  Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G; BENEDICT Study Group. Ruggenenti P, et al. J Am Soc Nephrol. 2006 Dec;17(12):3472-81. doi: 10.1681/ASN.2006060560. Epub 2006 Nov 2. J Am Soc Nephrol. 2006. PMID: 17082240 Clinical Trial.
• Preventing microalbuminuria in type 2 diabetes.

  Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G; Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators. Ruggenenti P, et al. N Engl J Med. 2004 Nov 4;351(19):1941-51. doi: 10.1056/NEJMoa042167. Epub 2004 Oct 31. N Engl J Med. 2004. PMID: 15516697 Clinical Trial.
• Treatment of hypertension in patients with diabetes mellitus.

  Agarwal R. Agarwal R. Indian Heart J. 2001 May-Jun;53(3):361-9. Indian Heart J. 2001. PMID: 11516043 Review. No abstract available.
• [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].

  Tsuchida H, Kimura K. Tsuchida H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:617-22. Nihon Rinsho. 2004. PMID: 15171445 Review. Japanese. No abstract available.